Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EnVAX-A71 Phase II Dose-Finding Study in Children
NCT03268083Phase 2Completed
- Sponsor
- Enimmune
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of envax-a71 in enterovirus 71 infection, sponsored by Enimmune. Started Jul 2016; status: completed.
02
Drugs
envax-a71
03
Conditions
enterovirus 71 infection
Beyond the preview
Go deeper on NCT03268083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03268083.